DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Notification of Renewal Deadline Extension
December 29, 2020

State Surgeon General Scott A. Rivkees issued Emergency Order 20-015 granting licensure renewal extensions
Continue reading


Potential Spam Alert
November 18, 2020

The Department of Health, Division of Medical Quality Assurance is warning Florida health care practitioners about fraudulent calls that have been received by multiple licensees. Continue reading




Supporting Documents
Medical Degree Verification
NICA FORM
Postgraduate Training Verification